References
- HaussDJOral lipid-based formulationsAdv Drug Deliv Rev200759766767617618704
- PiaoHKamiyaNWatanabeJOral delivery of diclofenac sodium using a novel solid-in-oil suspensionInt J Pharm20063131–215916216530362
- WuWWangYQueLEnhanced bioavailability of silymarin by self-microemulsifying drug delivery systemEur J Pharm Biopharm200663328829416527467
- StrickleyRGSolubilizing excipients in oral and injectable formulationsPharm Res200421220123015032302
- PorterCJTrevaskisNLCharmanWNLipids and lipid-based formulations: Optimizing the oral delivery of lipophilic drugsNat Rev Drug Discov20076323124817330072
- KhooSMShacklefordDMPorterCJEdwardsGACharmanWNIntestinal lymphatic transport of halofantrine occurs after oral administration of a unit-dose lipid-based formulation to fasted dogsPharm Res20032091460146514567642
- ChengMBWangJCLiYHCharacterization of water-in-oil microemulsion for oral delivery of earthworm fibrinolytic enzymeJ Control Release20081291414818474405
- PrasadYVPuthliSPEaimtrakarnSEnhanced intestinal absorption of vancomycin with Labrasol and D-alpha-tocopheryl PEG 1000 succinate in ratsInt J Pharm2003250118119012480284
- ConstantinidesPPLipid microemulsions for improving drug dissolution and oral absorption: Physical and biopharmaceutical aspectsPharm Res19951211156115728592652
- LiuYNZhouZMChenPEvidence that hydroxysafflor yellow A protects the heart against ischaemia-reperfusion injury by inhibiting mitochondrial permeability transition pore openingClin Exp Pharmacol Physiol200835221121617941891
- ZhuHWangZMaCNeuroprotective effects of hydroxysafflor yellow A: In vivo and in vitro studiesPlanta Med200369542943312802724
- ZhuHBWangZHTianJWFuFHLiuKLiCLProtective effect of hydroxy safflor yellow A on experimental cerebral ischemia in ratsYao Xue Xue Bao2005401211441146 Chinese.16496682
- WangSSunMPingQEnhancing effect of Labrafac Lipophile WL 1349 on oral bioavailability of hydroxysafflor yellow A in ratsInt J Pharm20083581–219820418417306
- QiJSunMPingQThe mechanisms for enhanced oral absorption of hydroxysafflor yellow A by Chuanxiong volatile oilPlanta Med201076878679220033864
- AboofazeliRLawrenceMJInvestigations into the formation and characterization of phospholipid microemulsions. I Pseudoternary phase diagrams of systems containing water-lecithin-alcohol-isopropyl myristateInt J Pharm1993931–3161175
- TavakoliSHajrasoulihaARJabehdar-MaralaniPModulated hemodynamic response to clonidine in bile duct-ligated rats: The role of nitric oxideEur J Pharmacol20065421–314815316824510
- ZangenbergNHMullertzAKristensenHGHovgaardLA dynamic in vitro lipolysis model. I. Controlling the rate of lipolysis by continuous addition of calciumEur J Pharm Sci200114211512211500257
- ZangenbergNHMullertzAKristensenHGHovgaardLA dynamic in vitro lipolysis model. II: Evaluation of the modelEur J Pharm Sci200114323724411576829
- FatourosDGBergenstahlBMullertzAMorphological observations on a lipid-based drug delivery system during in vitro digestionEur J Pharm Sci2007312859417418543
- WilsonTHWisemanGThe use of sacs of everted small intestine for the study of the transference of substances from the mucosal to the serosal surfaceJ Physiol195412311162513131249
- CornaireGWoodleyJHermannPCloarecAArellanoCHouinGImpact of excipients on the absorption of P-glycoprotein substrates in vitro and in vivoInt J Pharm2004278111913115158955
- QiJJinXHuangLPingQSimultaneous determination of hydroxysafflor yellow A and ferulic acid in rat plasma after oral administration of the co-extractum of Rhizoma chuanxiong and Flos Carthami by HPLC-diode array detectorBiomed Chromatogr200721881682217441216
- FormarizTPChiavacciLASarmentoVHStructural changes of biocompatible neutral microemulsions stabilized by mixed surfactant containing soya phosphatidylcholine and their relationship with doxorubicin releaseColloids Surf B Biointerfaces200863228729518313903
- YangSCBenitaSEnhanced absorption and drug targeting by positively charged submicron emulsionsDrug Develop Res201050476486
- AlanyRGRadesTAgatonovic-KustrinSDaviesNMTuckerIGEffects of alcohols and diols on the phase behaviour of quaternary systemsInt J Pharm2000196214114510699705
- KawakamiKYoshikawaTHayashiTNishiharaYMasudaKMicroemulsion formulation for enhanced absorption of poorly soluble drugs. II. In vivo studyJ Control Release2002811–2758211992680
- ShaXYanGWuYLiJFangXEffect of self-microemulsifying drug delivery systems containing Labrasol on tight junctions in Caco-2 cellsEur J Pharm Sci200524547748615784337
- YehPYSmithPLEllensHEffect of medium-chain glycerides on physiological properties of rabbit intestinal epithelium in vitroPharm Res1994118114811547971716
- ShiauYFKelemenRJReedMAAcidic mucin layer facilitates micelle dissociation and fatty acid diffusionAm J Physiol19902594 Pt 1G671G6752221076
- ThomsonABSchoellerCKeelanMSmithLClandininMTLipid absorption: Passing through the unstirred layers, brush-border membrane, and beyondCan J Physiol Pharmacol19937185315558306192
- DahanAHoffmanAThe effect of different lipid based formulations on the oral absorption of lipophilic drugs: The ability of in vitro lipolysis and consecutive ex vivo intestinal permeability data to predict in vivo bioavailability in ratsEur J Pharm Biopharm20076719610517329087
- KimuraYHosodaYShimaMAdachiSMatsunoRPhysicochemical properties of fatty acids for assessing the threshold concentration to enhance the absorption of a hydrophilic substanceBiosci Biotechnol Biochem1998623443447
- AungstBJIntestinal permeation enhancersJ Pharm Sci200089442944210737905